Abstract

Cervical cancer is the third leading cause of cancer related deaths worldwide. death in all cancer cases in the world. Screening for cervical cancer can help prevent it, with methods like Visual Inspection with Acetic Acid (VIA). The VIA examination has traditionally been conducted visually, without the aid of tools, leading to subjective results and a lack of documentation of examination outcomes. Digital technologies such as the "OptiLab NVeCam" aid in VIA implementation. This study aims to evaluate the impact of the " OptiLab NVeCam" on VIA accuracy. It employs a quasi-experimental design with a single-group pre-post test conducted in Java in 2022, involving 71 midwives who perform VIA. The study utilized accidental sampling and analyzed via the Wilcoxon test. Results indicate significant improvement in VIA accuracy using the Digital Colposcope among midwives (p = 0.008). Furthermore, VIA results obtained with the " OptiLab NVeCam " was consistent with validator, demonstrating its efficacy and accuracy in cervical cancer screening. he introduction of " OptiLab NVeCam " addresses these issues in VIA examinations, offering a solution for more accurate and documented screening outcomes.

There is no Figure or data content available for this article

References

• H. Sung et al., “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA: A Cancer Journal for Clinicians, vol. 71, no. 3. pp. 209–249, 2021. doi: 10.3322/caac.21660.
• The Global Cancer Observatory, “International Agency for Research on Cancer,” 2020.
• The Global Cancer Observatory, “Cancer Incident in Indonesia,” 2020.
• E. R. Allanson, N. Phoolcharoen, M. P. Salcedo, B. Fellman, and K. M. Schmeler, “Accuracy of Smartphone Images of the Cervix After Acetic Acid Application for Diagnosing Cervical Intraepithelial Neoplasia Grade 2 or Greater in Women With Positive Cervical Screening: A Systematic Review and Meta-Analysis,” JCO Glob. Oncol., no. 7, pp. 1711–1721, 2021, doi: 10.1200/go.21.00168.
• Kementerian Kesehatan RI, “Ministry of Helath Regulation No.29/2017 on Breast Cancer and Cervical Cancer Management,” 2017.
• P. Dunyo, K. Effah, and E. A. Udofia, “Factors associated with late presentation of cervical cancer cases at a district hospital: A retrospective study,” BMC Public Health, vol. 18, pp. 1–10, 2018.
• K. Bhattachan et al., “Evaluation of Abnormal Cervix with Visual Inspection under Acetic Acid and Colposcopy,” J. Nepal Health Res. Counc., vol. 17, no. 1, pp. 76–79, 2019, doi: 10.33314/jnhrc.1809.
• P. Sinha, P. Srivastava, and A. Srivastava, “Comparison of Visual Inspection with Acetic Acid and the Pap Smear for Cervical Cancer Screening,” Acta Cytol., vol. 62, no. 1, pp. 34–38, 2018, doi: 10.1159/000484036.
• P. Benrjee, Dipanwita; Mittal Srabani; Mandal, Ranajit; Basu, “Screening technologies for cervical cancer: Overview,” Cytojournal, vol. 19, no. 23, 2022, doi: 10.25259/CMAS_03_04_2021.
• V. Singh, K. Varma, M. Bhargava, V. Misra, M. Singh, and R. Singh, “Evaluation of Role of Visual Inspection Using Acetic Acid (VIA) and Exfoliative Cytology in Screening and Early Detection of Oral Premalignant Lesions and Oral Cancer,” Asian Pacific J. Cancer Prev., vol. 22, no. 7, pp. 2273–2278, 2021, doi: 10.31557/APJCP.2021.22.7.2273.
• Ó. Gamboa et al., “Visual techniques for cervical cancer screening in Colombia,” Biomedica, vol. 39, no. 1, pp. 65–74, 2019, doi: 10.7705/biomedica.v39i1.4007.
• E. S. Aoki et al., “National screening programs for cervical cancer in Asian countries,” J. Gynecol. Oncol., vol. 31, no. 3, pp. 1–9, 2020, doi: 10.3802/jgo.2020.31.e55.
• A. Destaw, M. Midaksa, A. Addissie, E. J. Kantelhardt, and M. Gizaw, “Cervical cancer screening ‘see and treat approach’: real-life uptake after invitation and associated factors at health facilities in Gondar, Northwest Ethiopia,” BMC Cancer, vol. 21, no. 1, pp. 1–9, 2021, doi: 10.1186/s12885-021-08761-0.
• J. Egede, P. Ibekwe, U. Agwu, E. Nwizu, F. Iyare, and L. Ajah, “Comparison of the accuracy of Papanicolaou test cytology, visual inspection with acetic acid, and visual inspection with lugol iodine in screening for cervical neoplasia in southeast Nigeria,” J. Glob. Oncol., vol. 2018, no. 4, pp. 1–9, 2018, doi: 10.1200/JGO.17.00127.
• V. Hayumbu, J. Hangoma, B. M. Hamooya, M. Malumani, and S. K. Masenga, “Cervical cancer and precancerous cervical lesions detected using visual inspection with acetic acid at Livingstone Teaching Hospital,” Pan Afr. Med. J., vol. 40, 2021, doi: 10.11604/pamj.2021.40.235.32300.
• A. Lohiya, R. A. Daniel, D. Kumar, C. Varghese, R. S. Rath, Rama Shankar, Abdulkader, and B. Nongkynrih, “Effectiveness of Visual Inspection with Acetic Acid (VIA) Screening on Cervical Cancer Mortality and Incidence - A Systematic Review and Meta-Analysis,” Asian Pacific J. Cancer Prev., vol. 23, no. 2, pp. 399–407, 2022, doi: 10.31557/APJCP.2022.23.2.399.
• O. Fatimah, “Transformation of Health System within the Scope of the Tridharma of Higher Education at Poltekkes Kemenkes Organizational Structure,” 2022.
• J. Sami et al., “Smartphone-Based Visual Inspection with Acetic Acid: An Innovative Tool to Improve Cervical Cancer Screening in Low-Resource Setting,” Healthc., vol. 10, no. 2, 2022, doi: 10.3390/healthcare10020391.
• B. Goel, A. Desouza, A. Sehgal, and S. Dubey, “Looking Beyond VIA to Improve Cervical Cancer Screening in Low Resource Settings,” J. Obstet. Gynecol. India, vol. 72, no. 6, pp. 503–508, 2022, doi: 10.1007/s13224-022-01674-3.
• N. Setiyawati, L. Herawati, H. P. Wahyuningsih, and Y. Kusmiyati, “The Role Of Digital Health Technology In Cervical Cancer Screening?: Review Literature,” Webology, vol. 19, no. 3, pp. 1809–1816, 2022.
• B. Setiyawati, Nanik; Herawati, Lucky;Wahyuningsih, HP;Widyasih, Hesty;Purnamaningrum, YE;Estiwidani, D;Wijanarka, Agus;Suwerda, Teropong Digital for Cervical Cancer Screening A New Breakthrough Improves Accuracy Early Detection of Cervical Cancer. Yogyakarta: Gaza Library Publishing, 2022.
• Law No 4 of 2019 Midwifery. Jakarta, 2019.
• H. Salehniya, Z. Momenimovahed, L. Allahqoli, S. Momenimohvahed, and I. Alkatout, “Factors related to cervical cancer screening among Asian women,” Eur. Rev. Med. Pharmacol. Sci., vol. 25, no. 19, pp. 6109–6122, 2021, doi: 10.26355/eurrev_202110_26889.
• M. Z. Wang et al., “Clinical Performance of Human Papillomavirus Testing and Visual Inspection with Acetic Acid in Primary, Combination, and Sequential Cervical Cancer Screening in China,” Sex. Transm. Dis., vol. 46, no. 8, pp. 540–547, 2019, doi: 10.1097/OLQ.0000000000001026.
• H. Setiyawati, Nanik;Kusmiyati, Yuni;Herawati, Lucky;Wahyuningsih, Heni;Purnamaningrum, YE;Estiwidani, Dwiana;Widyasih, “The Use of Teropong Digital for Cervical Cancer Screening In Acetic Acid Visual Inspection (VIA) as an Effort to Increase Maternal Knowledge,” J. Pengabdi. Mandiri, vol. 1, no. 6, 2022, [Online]. Available: https://bajangjournal.com/index.php/JPM/article/view/2524

How to Cite This

Article Metrics

Download Statistics

Other Statistics

Copyright and Permissions

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Data Availability